|
1.
|
Abraxane
|
Trockensub 100 mg
|
Durchstf 1 Stk
|
338.78
|
405.30
|
|
|
L
|
Nein
|
63182001
|
Bristol-Myers Squibb SA
|
Complexus paclitaxeli et albumini humani
|
20247
|
01.04.2015
|
|
|
|
|
07.16.10.
|
L01CD01
|
|
2.
|
Adcetris
|
Trockensub 50 mg
|
Durchstf 1 Stk
|
3358.75
|
3688.70
|
|
|
L
|
Nein
|
62132001
|
Takeda Pharma AG
|
Brentuximabum vedotinum
|
19989
|
01.04.2013
|
|
|
|
|
07.16.10.
|
L01FX05
|
|
3.
|
Adcetris
|
Trockensub 50 mg
|
Durchstf 2 Stk
|
6717.49
|
7131.45
|
|
|
L
|
Nein
|
62132003
|
Takeda Pharma AG
|
Brentuximabum vedotinum
|
19989
|
01.11.2014
|
|
|
|
|
07.16.10.
|
L01FX05
|
|
4.
|
Adriblastin RD
|
Trockensub 10 mg c solv
|
Durchstf 1 Stk
|
18.23
|
37.35
|
|
|
|
Nein
|
50357015
|
Pfizer AG
|
Doxorubicini hydrochloridum
|
15691
|
15.03.1991
|
|
|
|
|
07.16.10.
|
L01DB01
|
|
5.
|
Adriblastin RD
|
Trockensub 50 mg c Solv
|
Durchstf 1 Stk
|
74.43
|
101.85
|
|
|
|
Nein
|
50357001
|
Pfizer AG
|
Doxorubicini hydrochloridum
|
15691
|
01.07.2022
|
|
|
|
|
07.16.10.
|
L01DB01
|
|
6.
|
Adriblastin Sol
|
Inj Lös 10 mg/5ml
|
Cytosafe 5 ml
|
12.60
|
26.75
|
|
|
|
Nein
|
50358054
|
Pfizer AG
|
Doxorubicini hydrochloridum
|
15876
|
01.04.2002
|
|
|
|
O
|
07.16.10.
|
L01DB01
|
|
7.
|
Adriblastin Sol
|
Inj Lös 20 mg/10ml
|
Cytosafe 10 ml
|
33.03
|
54.30
|
|
|
|
Nein
|
50358062
|
Pfizer AG
|
Doxorubicini hydrochloridum
|
15876
|
01.04.2002
|
|
|
|
O
|
07.16.10.
|
L01DB01
|
|
8.
|
Adriblastin Sol
|
Inj Lös 50 mg/25ml
|
2 Cytosafe 25 ml
|
122.97
|
157.55
|
|
|
|
Nein
|
50358070
|
Pfizer AG
|
Doxorubicini hydrochloridum
|
15876
|
01.04.2002
|
|
|
|
O
|
07.16.10.
|
L01DB01
|
|
9.
|
Afinitor
|
Tabl 5 mg
|
30 Stk
|
1122.49
|
1292.60
|
|
|
L
|
Nein
|
59174001
|
Novartis Pharma Schweiz AG
|
Everolimusum
|
19175
|
01.02.2010
|
|
|
|
|
07.16.10.
|
L01EG02
|
|
10.
|
Afinitor
|
Tabl 10 mg
|
30 Stk
|
1615.88
|
1833.70
|
|
|
L
|
Nein
|
59174002
|
Novartis Pharma Schweiz AG
|
Everolimusum
|
19175
|
01.02.2010
|
|
|
|
|
07.16.10.
|
L01EG02
|